KTOS Posts 30% Revenue Jump in Q2, but Critical Cash and Backlog Metrics Remain Unclear

What happened

Kratos reported Q2 2026 revenues of $458.8 million, up 30.5% year-over-year and 19.1% organically, extending its streak of double-digit top-line growth. The headline figure comfortably exceeds the prior-year quarter’s $351.5 million and keeps full-year guidance within reach. However, the release provided no update on funded backlog, operating cash flow, or working capital—the very metrics that our WAIT thesis flagged as make-or-break for the stock. Until we see whether DSO, inventory, and unbilled receivables improved alongside revenue, the growth number offers limited comfort. The market’s drone-premium narrative remains on probation until the full 10-Q reveals if conversion is catching up with sales.

Implication

The 30% revenue growth affirms demand strength and supports management’s guidance, but our WAIT thesis demanded more than top-line expansion. Without visibility into funded backlog growth, DSO trends, and free cash flow, the report fails to address the core concerns that have kept the stock under pressure. The next 24 hours will be critical: if the accompanying 10-Q shows funded backlog rising, inventory growth slowing relative to sales, and operating cash flow turning positive, the thesis strengthens toward the bull case. If those metrics stall or worsen, the bear-case probability rises. For now, the report is a placeholder, not a catalyst.

Thesis delta

The Q2 revenue print lands solid demand but does not alter our WAIT stance because the thesis-breaking variables (backlog conversion, working-capital stability, unmanned follow-ons) remain unknown. No shift is warranted until the full earnings release provides evidence that growth is translating into improved cash generation. The margin of safety continues to rely on balance-sheet liquidity, not operating momentum.